Alcon Inc. (LON:0A0D)

Market Cap	27.83B -18.4%
Revenue (ttm)	7.73B +4.9%
Net Income	728.14M -3.7%
EPS	1.47 -3.4%
Shares Out	n/a
PE Ratio	38.21
Forward PE	21.52
Dividend	0.25 (0.43%)
Ex-Dividend Date	May 13, 2025

Volume	567,612
Average Volume	392,894
Open	59.42
Previous Close	60.40
Day's Range	59.19 - 60.72
52-Week Range	56.46 - 86.94
Beta	0.70
RSI	46.79
Earnings Date	May 6, 2026

About Alcon

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company’s cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1945
• Employees: 25,942
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0A0D

Financial Performance

In 2025, Alcon's revenue was $10.40 billion, an increase of 4.94% compared to the previous year's $9.91 billion. Earnings were $980.00 million, a decrease of -3.73%.

Financial numbers in USD